INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $156,000 | -20.8% | 21,766 | +2.4% | 0.05% | -20.7% |
| Q2 2021 | $197,000 | +4.2% | 21,266 | +3.9% | 0.06% | -6.5% |
| Q1 2021 | $189,000 | -8.3% | 20,466 | 0.0% | 0.06% | -47.9% |
| Q4 2020 | $206,000 | -10.8% | 20,466 | +2.5% | 0.12% | -27.4% |
| Q3 2020 | $231,000 | -56.5% | 19,966 | +1.3% | 0.16% | -59.0% |
| Q2 2020 | $531,000 | +263.7% | 19,716 | 0.0% | 0.40% | +312.4% |
| Q1 2020 | $146,000 | +124.6% | 19,716 | 0.0% | 0.10% | +142.5% |
| Q4 2019 | $65,000 | +71.1% | 19,716 | +5.3% | 0.04% | +60.0% |
| Q3 2019 | $38,000 | -17.4% | 18,716 | +19.1% | 0.02% | -21.9% |
| Q2 2019 | $46,000 | -9.8% | 15,716 | +14.6% | 0.03% | -15.8% |
| Q1 2019 | $51,000 | -5.6% | 13,716 | 0.0% | 0.04% | -22.4% |
| Q4 2018 | $54,000 | – | 13,716 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |